Truthout
Big Pharma
Big Pharma and GOP Open About Plans to Obstruct Medicare Drug Price Reforms
While the reforms are less ambitious than what progressives wanted, they could still have a significant impact on costs.
Drug Industry’s Chief Lobbying Group’s Revenue Surpassed $609 Million in 2021
The Pharmaceutical Research and Manufacturers of America spent more money than ever on lobbying the federal government.
$35 Insulin Caps for Medicare Patients Is Not Enough
In 2021, nearly 1 in 5 U.S. adults with diabetes rationed their insulin. Most are not covered by the new price cap.
Pharma Claims Drug Price Reform Hurts Innovation. Experts Say That’s “Bullshit.”
As the Senate moved to adopt modest drug pricing negotiation measures, pharmaceutical companies made specious arguments.
Pharma Complains of “Tragic Loss” as Dems Take Modest Action to Curb Drug Prices
The Inflation Reduction Act requires Medicare to negotiate the prices of a small number of prescription drugs.
Confusion Over COVID Vaccine Safety Led to Many Avoidable Stillbirths
A lack of testing data and government guidance led many to avoid the COVID-19 vaccine during pregnancy.
Sanders Takes Aim at Big Oil, Big Pharma Concessions in Inflation Reduction Act
Sanders announced two amendments to get rid of Big Oil giveaways and allow Medicare to cover dental, vision and hearing.
GOP Opposition to Drug Pricing Bill Shows Scope of Big Pharma’s Grip on Congress
Republicans are opposing legislation that would lower drug costs for millions.
Sanders: Democrats’ Drug Pricing Plan “Goes Nowhere Near as Far as It Should”
Sen. Bernie Sanders suggested that pharmaceutical industry lobbying weakened the proposal.
Pharma Is Mobilizing to Tank Democrats’ Effort to Cut Prescription Drug Costs
The pharmaceutical industry is mobilizing its army of lobbyists to attack Senate Democrats' Medicare drug pricing plan.